D-VCd: The 1st FDA-approved AL amyloidosis treatment

02 Jul 2024
Dr. Herman Liu
Dr. Herman LiuSpecialist in Haematology & Haematological Oncology; Private practice; Hong Kong
Dr. Herman Liu
Dr. Herman Liu Specialist in Haematology & Haematological Oncology; Private practice; Hong Kong
AL amyloidosis is a progressive, underdiagnosed disease with multiorgan involvement. Watch this video to gain insights from Dr Herman Liu (Specialist in haematology in Hong Kong) on establishing an early and accurate diagnosis and the recent change in the treatment landscape of AL amyloidosis.

This video is supported by Janssen, a division of Johnson & Johnson (HK) Ltd.

Related MIMS Drugs